In dogs, hemophilia A is known to affect different breeds. This is a case report describing hemophilia A in a litter of Border Collies. A privately owned bitch and her puppies (n = 7) were presented to the referring veterinarian after acute hematoma formation in the male offspring (n = 3) following microchip implantation. Global coagulation testing, as well as determination of factor VIII and IX activity, were carried out. Based on the results, factor VIII deficiency was suspected. Two of the affected male puppies were euthanized within a few days. Genetic testing of the mother and the surviving male puppy resulted in the description of a deletion in exon 14 of the F8 gene. This c.3206delA variant leads to a frameshift in amino acid sequence and a premature stop codon (p.Asn1069IlefsTer7). The detection of the mutation and consequent testing of related dogs revealed that the deletion most likely had occurred spontaneously in the mother and had been transmitted to several of her offspring in different litters. Identified carriers were taken out of the breeding scheme. It is concluded that genetic testing in the context of suspected genetic disease can lead to preventive measures, including timely exclusion of carriers from breeding.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/vcp.13312 | DOI Listing |
Vet Clin Pathol
December 2023
Laboklin GmbH & Co. KG, Bad Kissingen, Germany.
In dogs, hemophilia A is known to affect different breeds. This is a case report describing hemophilia A in a litter of Border Collies. A privately owned bitch and her puppies (n = 7) were presented to the referring veterinarian after acute hematoma formation in the male offspring (n = 3) following microchip implantation.
View Article and Find Full Text PDFAnim Genet
October 2023
Department of Veterinary Biosciences, University of Helsinki, Helsinki, Finland.
Hemophilia A is the most common inherited coagulation factor disorder in dogs. It manifests as excessive bleeding resulting from pathogenic variants in the X-chromosomal F8 gene encoding coagulation factor VIII (FVIII) protein. In this study, we performed careful clinical phenotyping to confirm hemophilia A in two distinct Labrador Retriever (LR) pedigrees.
View Article and Find Full Text PDFBlood Adv
August 2020
World Federation of Hemophilia, Montreal, QC, Canada.
The treatment of hemophilia, which has undergone many transformative changes over the past 60 years, is poised for yet another disruptive change: the use of gene therapy to produce functional cures in some persons with hemophilia A or B. The path toward achieving subnormal to normal levels of factor VIII and factor IX activity has not been straightforward and is littered with failures over these past 25 years. Through setbacks and iteration, adeno-associated virus (AAV) proved to be a useful vector to carry the factor VIII and IX transgenes; once cassettes were optimized and dose escalation proceeded, therapeutic levels of clotting factors were achieved by several groups.
View Article and Find Full Text PDFJ Small Anim Pract
July 2009
Department of Veterinary Medicine, University ofCambridge, Madingley Road, Cambridge CB3 0ES, UK.
Inherited coagulopathies are reported in a number of dog breeds. However, to date, there is no report of Weimaraners suffering factor VIII deficiency (haemophilia A). We report the discovery of haemophilia A in both males from a single litter of Weimaraners.
View Article and Find Full Text PDFN Z Vet J
April 2000
Pathobiology Section, Institute of Veterinary Animal and Biomedical Sciences, Massey University, Private Bag 11222, Palmerston North, New Zealand.
Aim: To investigate haemorrhagic diathesis in several males in a litter of Siberian huskies.
Methods: Activated partial thromboplastin time, prothrombin time, and Factor VIII and Factor IX concentrations were measured in citrated whole blood samples.
Results: Males in the litter had decreased Factor VIII concentrations.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!